Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Accounts Payables (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Accounts Payables for 16 consecutive years, with $3.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Accounts Payables rose 107.04% to $3.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.6 million, a 107.04% increase, with the full-year FY2025 number at $3.6 million, up 107.04% from a year prior.
  • Accounts Payables was $3.6 million for Q4 2025 at Lemaitre Vascular, up from $3.5 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $4.9 million in Q2 2025 to a low of $1.7 million in Q3 2024.
  • A 5-year average of $2.9 million and a median of $2.9 million in 2022 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: tumbled 62.23% in 2024, then surged 146.32% in 2025.
  • Lemaitre Vascular's Accounts Payables stood at $2.3 million in 2021, then increased by 24.06% to $2.9 million in 2022, then rose by 28.63% to $3.7 million in 2023, then crashed by 52.84% to $1.8 million in 2024, then surged by 107.04% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Accounts Payables are $3.6 million (Q4 2025), $3.5 million (Q3 2025), and $4.9 million (Q2 2025).